A corollary of a productive year!! Hope to be more prolific in the following years. Many thanks for all collaborators and mentors that made this possible!
@ECCMID @scare_global
🆕Happy to publish our study addressing clinical epidemiology of carbapenem-resistant Klebsiella pneumoniae BSI in an OXA-48 endemic setting @akovamurat@scare_global
https://t.co/4nUfZ9oVhg
I'm very proud of being a scientific committee member of @scare_global. We kicked off the largest study to date investigating molecular and clinical epidemiological features of hospital-acquired BSIs in Turkey. Thank you for all the participants and those who made this possible.
@i_AMResponsible Scare is a study group working on carbapenem resistance from Turkey and open to all scientists from the world! For detailed information please visit our website!
Join us for our upcoming webinar.
4 March | 4-5:30pm CET
How can we apply the lessons learned from #COVID-19 to tackle drug resistance and ensure access to appropriate #antibiotics?
👉Registration is open: https://t.co/CEbDR1i8Al👈
Our second installment of the new open-access COVID-19 websymposium series is on Antimicrobial Stewardship and will take place on Thursday, February 18th at 16:00 CET.
You can see the programme and register now on our website here: https://t.co/SLWucH8Vvr
"Following the recommendations of the Interagency Coordination Group on #AntimicrobialResistance, we have come together to advocate for urgent action to combat the threat of AMR, to reinvigorate global political momentum, & to catalyze action in an One Health approach"-@DrTedros